Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Litzow

Showing results (111-120 of 457) with videos related to

Pageof 46
Sort By:
Leukemia & Lymphoma|August 20, 2020
Updated safety of midostaurin plus chemotherapy in newly diagnosed <i>FLT3</i> mutation-positive acute myeloid leukemia: the RADIUS-X expanded access programGail J Roboz, Stephen A Strickland, Mark R Litzow, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2003
Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantationNoel M Caplice, T Jared Bunch, Paul G Stalboerger, et al.
British Journal of Haematology|March 6, 2008
Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disordersShaji K Kumar, David Dingli, Martha Q Lacy, et al.
American Journal of Hematology|April 23, 2008
Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysisShaji K Kumar, David Dingli, Martha Q Lacy, et al.
Leukemia Research|January 18, 2006
Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997Larry D Cripe, Kevin Rader, Martin S Tallman, et al.
Cancer|April 12, 2023
Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasmsRaoul Tibes, Heidi E Kosiorek, Amylou C Dueck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2019
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell TransplantationAnthony S Stein, Hagop Kantarjian, Nicola Gökbuget, et al.
Leukemia Research|July 12, 2011
Correlation of CYP2B6, CYP2C19, ABCC4 and SOD2 genotype with outcomes in allogeneic blood and marrow transplant patientsJohn L Black, Mark R Litzow, William J Hogan, et al.
Blood|June 25, 2005
Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapyMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2015
The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic ReviewHafsa M Chaudhry, Alison J Bruce, Robert C Wolf, et al.
Pageof 46

Showing results (111-120 of 457) with videos related to

Sort By:
Pageof 46
Leukemia & Lymphoma|August 20, 2020
Updated safety of midostaurin plus chemotherapy in newly diagnosed <i>FLT3</i> mutation-positive acute myeloid leukemia: the RADIUS-X expanded access programGail J Roboz, Stephen A Strickland, Mark R Litzow, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2003
Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantationNoel M Caplice, T Jared Bunch, Paul G Stalboerger, et al.
British Journal of Haematology|March 6, 2008
Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disordersShaji K Kumar, David Dingli, Martha Q Lacy, et al.
American Journal of Hematology|April 23, 2008
Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysisShaji K Kumar, David Dingli, Martha Q Lacy, et al.
Leukemia Research|January 18, 2006
Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997Larry D Cripe, Kevin Rader, Martin S Tallman, et al.
Cancer|April 12, 2023
Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasmsRaoul Tibes, Heidi E Kosiorek, Amylou C Dueck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2019
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell TransplantationAnthony S Stein, Hagop Kantarjian, Nicola Gökbuget, et al.
Leukemia Research|July 12, 2011
Correlation of CYP2B6, CYP2C19, ABCC4 and SOD2 genotype with outcomes in allogeneic blood and marrow transplant patientsJohn L Black, Mark R Litzow, William J Hogan, et al.
Blood|June 25, 2005
Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapyMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2015
The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic ReviewHafsa M Chaudhry, Alison J Bruce, Robert C Wolf, et al.
Pageof 46